CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00001746
NCT00001746N/ACompleted

Evaluation of Patients With Known or Suspected Inherited Heart Disease (Screening Protocol)

National Heart, Lung, and Blood Institute (NHLBI)·observational·Posted Nov 4, 1999·Updated Mar 5, 2008

In Brief

An observational study for Heart Disease and Hypertrophic Cardiomyopathy. Completed, across 1 site.

Detailed Summary

Genetically inherited heart diseases like hypertrophic cardiomyopathy (HCM) are conditions affecting the heart passed on to family members by abnormalities in genetic information. These conditions are responsible for many heart related deaths and illnesses. Presently, there are several research studies being conducted in order to improve the understanding of disease processes and symptoms associated with genetically inherited heart diseases. This study is designed to determine the eligibility of patients diagnosed with or suspected to have inherited heart disease to participate in these research studies.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 4, 1999
Enrollment StartApr 1, 1998
Study CompletionApr 1, 2003
TodayJul 2, 2026
Posted 26.7 years ago